ANG Promotes Proliferation and Invasion of the Cell of Lung Squamous Carcinoma by Directly Up-Regulating HMGA2
- PMID: 27162546
- PMCID: PMC4860804
- DOI: 10.7150/jca.14440
ANG Promotes Proliferation and Invasion of the Cell of Lung Squamous Carcinoma by Directly Up-Regulating HMGA2
Abstract
Objective: To determine the mechanism of Angiogenin(ANG) function involved in the carcinogenesis of lung squamous cell carcinoma.
Methods: 12 patients' normal tissue and cancerous tissue were collected. ANG expression in the squamous cell carcinoma of the lung was evaluated by qRT-PCR and western-blot. The regulation of ANG on proliferation, migration, invasion, and apoptosis of SK-MES-1 cells were analyzed by Cell Counting Kit-8, Transwell migration chamber, Transwell invasion chamber, and Annexin V-FITC assay, respectively. PCR array was utilized for screening potential target genes of ANG. Chromatin immunoprecipitation(ChIP) assays and luciferase assay were adopted for investigation of ANG's direct regulation on HMGA2.
Results: ANG expression is increased in the squamous cell carcinoma of the lung tissue. In vitro experiments results indicated that overexpression of ANG promotes proliferation and invasion capability of SK-MES-1 cells. The candidate proliferation, migration, and invasion related ANG target gene found was HMGA2, expression levels of which were also enhanced in lung squamous cell carcinoma tissue. The direct regulation of ANG on HMGA2 was verified by ChIP and luciferase assay results. Furthermore, down-regulating HMGA2 significantly alleviated the suppression effects of ANG on proliferation, migration, and invasion of SK-MES-1 cells.
Conclusions: Our data illustrated the mechanisms that ANG promoted the cell of SQCLC proliferation, migration, and invasion capacity via directly up-regulating HMGA2.
Keywords: Angiogenin; HMGA2.; lung squamous cell carcinoma.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
Similar articles
-
miR-541 suppresses proliferation and invasion of squamous cell lung carcinoma cell lines via directly targeting high-mobility group AT-hook 2.Cancer Med. 2018 Jun;7(6):2581-2591. doi: 10.1002/cam4.1491. Epub 2018 Apr 16. Cancer Med. 2018. PMID: 29659195 Free PMC article.
-
Angiogenin elevates the invasive potential of squamous cell lung carcinoma cells through epithelial‑mesenchymal transition.Oncol Rep. 2016 Nov;36(5):2836-2842. doi: 10.3892/or.2016.5107. Epub 2016 Sep 19. Oncol Rep. 2016. PMID: 27667357
-
Angiogenin regulates epithelial-mesenchymal transition of hepatocellular carcinoma through upregulation of HMGA2.Pharmazie. 2019 May 1;74(5):301-304. doi: 10.1691/ph.2019.8943. Pharmazie. 2019. PMID: 31109401
-
Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors.Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):1693-1699. doi: 10.26355/eurrev_201803_14582. Eur Rev Med Pharmacol Sci. 2018. PMID: 29630114
-
MiR-1297 promotes apoptosis and inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting HMGA2.Int J Mol Med. 2015 Nov;36(5):1345-52. doi: 10.3892/ijmm.2015.2341. Epub 2015 Sep 10. Int J Mol Med. 2015. PMID: 26398017
Cited by
-
HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition.Front Oncol. 2024 Feb 1;14:1320887. doi: 10.3389/fonc.2024.1320887. eCollection 2024. Front Oncol. 2024. PMID: 38361784 Free PMC article. Review.
-
Prognostic Roles of Glucose to Lymphocyte Ratio and Modified Glasgow Prognosis Score in Patients With Non-small Cell Lung Cancer.Front Nutr. 2022 May 10;9:871301. doi: 10.3389/fnut.2022.871301. eCollection 2022. Front Nutr. 2022. PMID: 35619963 Free PMC article.
-
Structure-Based Design of an RNase Chimera for Antimicrobial Therapy.Int J Mol Sci. 2021 Dec 22;23(1):95. doi: 10.3390/ijms23010095. Int J Mol Sci. 2021. PMID: 35008522 Free PMC article.
-
Increased Angiogenin Expression Correlates With Radiation Resistance and Predicts Poor Survival for Patients With Nasopharyngeal Carcinoma.Front Pharmacol. 2021 Aug 26;12:627935. doi: 10.3389/fphar.2021.627935. eCollection 2021. Front Pharmacol. 2021. PMID: 34512316 Free PMC article.
-
[Research Advances of Ang-2 in Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi. 2018 Nov 20;21(11):868-874. doi: 10.3779/j.issn.1009-3419.2018.11.09. Zhongguo Fei Ai Za Zhi. 2018. PMID: 30454550 Free PMC article. Review. Chinese.
References
-
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C. et al. Cancer statistics, 2006. CA: a cancer journal for clinicians. 2006;56:106–30. - PubMed
-
- Tan SX, Hu RC, Tan YL, Liu JJ, Liu WE. Promoter methylation-mediated downregulation of PRDM5 contributes to the development of lung squamous cell carcinoma. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35:4509–16. - PubMed
-
- Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung cancer (Amsterdam, Netherlands) 2014;84:13–22. - PubMed
-
- Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF. et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry. 1985;24:5480–6. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
